1 / 22

Suppressive Valacyclovir Therapy Soon After Initial Genital Herpes: Clinical Efficacy and Impact on Herpes-Related Qual

2. Early Suppressive Therapy for Genital Herpes Rationale. Genital herpes is the most prevalent STD in the US It is the one of greatest concern to sexually active people in the US behind HIV/AIDSThe need for suppressive therapy may be greatest in the first 6-12 months after acquisition when:Outb

gram
Download Presentation

Suppressive Valacyclovir Therapy Soon After Initial Genital Herpes: Clinical Efficacy and Impact on Herpes-Related Qual

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    1. 1 Suppressive Valacyclovir Therapy Soon After Initial Genital Herpes: Clinical Efficacy and Impact on Herpes-Related Quality of Life Hunter Handsfield Terri Warren Victory Murphy Mica Werner University of Washington and Public Health - Seattle & King County, Seattle, WA Westover Heights Clinic, Portland, OR

More Related